News
“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...
Biotechnology company Moderna (NASDAQ:MRNA) announced better-than-expected revenue in Q2 CY2025, but sales fell by 41.1% year ...
1don MSN
FDA considering pulling authorization of Pfizer’s COVID-19 vaccine for healthy children under 5
The Food and Drug Administration is considering pulling its authorization of Pfizer’s COVID-19 vaccine for healthy children ...
(Alliance News) - Baillie Gifford US Growth Trust PLC on Tuesday announced that it outperformed the S&P index in its financial year, as it expects the year ahead to present "significant opportunities" ...
Moderna's COVID-19 vaccine, Spikevax, has picked up a full U.S. approval in children aged 6 months to 11 years who are at an increased risk from the disease.
5d
Zacks Investment Research on MSNMerck Stock Down 4% Since Q2 Results: How to Play the Stock
Merck MRK stock has declined 4% since it announced second-quarter results on July 29 before market open. While the company’s ...
Moderna may offer substantial upside, but it's essential to consider the associated risks. Since hitting their peak in late ...
Respiratory syncytial virus vaccine uptake was low among older veterans, with disparities observed across demographic and social risk factors.
RSV vaccine recommended for adults 60+ with health issues, infants under 19 months, and all healthy adults 75+. Helps prevent ...
The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...
2d
Yours UK on MSNEverything you need to know about the RSV vaccine program in the UK
How you can make sure you get your RSV vaccine this winterThe UK is the first country to offer a RSV vaccine to help save the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results